The Forward P/E of Rigel Pharmaceuticals, Inc. (RIGL) is 13.27.

Forward P/E estimates how much investors are willing to pay today for each dollar of a company's expected future earnings. It serves as a valuation tool based on projected profitability rather than past performance.